This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

We invite people living with diabetes to join our United Through Diabetes event happening on World Diabetes Day!

Join our World Diabetes Day event?

Novo Nordisk Webinar Diabetes In Older Adults

This promotional webinar series has been developed, organised and funded by Novo Nordisk.  
Marketing and organisational support by Diabetes Professional Care and MDBriefCase.
For healthcare professionals only.
Product information may be discussed.

We are excited to bring you a series of 2 CPD accredited webinars along with 4 expert videos designed to help Healthcare Professionals (HCPs) provide better care to older adults living with diabetes. Please see the full details below for each of the training webinar.

Register for your free place

 

This webinar series also includes 4 expert videos which will be launched after each webinar:

  • Application of frailty assessment
  • Hypoglycaemia in the older adult
  • Antihyperglycaemic agent selection in the older adult
  • Deprescribing diabetes therapy 

 

Webinar #1 – Diabetes Management in an Ageing Population

Mon 12 Oct - 7pm to 8pm

The risk of type 2 diabetes increases with age. Older adults with diabetes are a diverse group of patients ranging from generally healthy and active to those with severe frailty. Patients with diabetes and frailty will normally require an adjustment of the treatment plan to mitigate the risks of intense treatment. This webinar will review the impact of frailty on diabetes and its management. 

Speakers: Su Down & Dr David Strain

Learning Objectives

  • Discuss the demographics of type 2 diabetes in an aging population
  • Review the relationship between diabetes, frailty and aging
  • Examine the pathophysiology of diabetes, hypoglycaemia and dementia


Register for your free place

Webinar #2 – Assessing Frailty in your Practice

Mon 26 Oct - 7pm to 8pm

Novo Nordisk product information will be discussed. Prescribing information and adverse event reporting information will be available at the meeting.

Frailty has a major impact on the management of patients with type 2 diabetes. These patients have different management strategies and HbA1c targets.  This webinar will review the healthcare professional assessment of frailty in the older adult, setting HbA1c targets and antihyperglycaemic therapy selection in this patient population. 

Speakers: Su Down & Dr David Strain

Learning Objectives

  • Assess frailty in patients with diabetes in primary care
  • Review the different frailty assessment tools and protocols
  • Determine appropriate HbA1c targets for older adults with diabetes and frailty
  • Individualise type 2 diabetes in an older adult with type 2 diabetes


Register for your free place

Speakers

Speakers

Su Down is a Nurse Consultant in Diabetes and is the Clinical Lead for the Intermediate Diabetes community service in Somerset. Nationally she is the Editor in Chief of the Journal of Diabetes Nursing and joint Vice Chair of the PCDS (Primary Care Diabetes Society). Former national roles have included being a TREND associate, board member of FIT (Forum for Injection Technique) and committee member of the Health Care Professionals Council of Diabetes UK.

Dr David Strain is a Senior Clinical Lecturer at the University of Exeter Medical School, with an expertise in microvascular structure and function. Clinically, he runs a community diabetes service for the older adult, and works as an in-patient stroke consultant. Prior to this, Dr Strain studied at Liverpool University before completing his Doctorate in Medicine on ‘The ethnic difference in the effects of insulin resistance on the vasculature’ at the International Centre for Cardiovascular Health, Imperial College, London.

Expert videos 

Video #1 - Application of frailty assessment

Not every older adult with diabetes should be managed similarly. This video will review the management of two patients who are the same age but with vastly different levels of frailty. It will also review frailty assessment and HbA1c target setting for these patients. 

Learning Objectives

  • Review frailty assessment in primary care
  • Discuss the pros and cons of the different frailty assessment tools
  • Determine appropriate HbA1c targets based on the level of frailty


Register to access the video

Video # 2 – Hypoglycaemia in the older adult

Hypoglycaemia can have a major impact on older adults. This video discusses the identification and management of hypoglycaemia. It will also review the impact of hypoglycaemia on older adults and strategies to mitigate its risk.

Learning Objectives

  • Define hypoglycaemia and its clinical presentation in older adults
  • Review the impact of hypoglycaemia on the frail older adult
  • Develop strategies to mitigate hypoglycaemia in older adults
     

Register to access the video

Video # 3 – Antihyperglycaemic agent selection in the older adult

 

There are a large variety of antihyperglycaemic agents to manage patients with type 2 diabetes. The benefits and risks of these agents can be different in an older adult with frailty compared to a younger individual. This video will review the key considerations when selecting antihyperglycemic therapy in your older adult patients. 

Learning objectives

  • Review the key considerations for antihyperglycaemic therapy selection in older adults
  • Discuss the benefits and risks of using antihyperglycaemic therapy classes in older adults
  • Individualize therapy in an older adult with type 2 diabetes


Register to access the video

Video # 4 – Deprescribing diabetes therapy   

As frailty increases in an older adult, the benefits from certain therapies increase while risks increase. This video will discuss how healthcare professionals should address clinical inertia in patients requiring treatment intensification but also reduce the pill burden in those older adults who would benefit from a decrease in pharmacotherapy.

Learning Objectives

  • Individualise therapy in two patients with type 2 diabetes with and without frailty
  • Minimise clinical inertia in the healthy older adult require treatment intensification
  • Reduce the pill burden in older adults with frailty


Register to access the video

Date of prep August 2020 - Job Code uk20tsm00127

Novo Nordisk Logo

Twitter

Sponsors

Diamond Sponsor

  • AstraZeneca

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Abbott

 

Gold Sponsor

  • GlucoRX

 

Gold Sponsor

  • Roche

 

Gold Sponsor

  • Insulet

 

Gold Sponsor

  • Lilly

 

Gold Sponsor

  • Napp Logo

 

Silver Sponsor

  • Sanofi

 

Silver Sponsor

  • CDEP

 

Silver Sponsor

  • glooko

 

Silver Sponsor

  • Aga Matrix

 

Silver Sponsor

  • Duet

 

Silver & Registration Sponsor

  • Diabetes Research & Wellness Foundation

 

Partners

Event Partner

  • NHS

Event Partner

  • ABCD

Event Partner

  • Diabetes Times

Event Partner

  • Trend

Event Partner

  • UKPCA

Media Partner

  • Caring Uk

Media Partner

  • Care Hub

Media Partner

  • Lifestyle Hub

Media Partner

  • Hospital Hub

Media Partner

  • Hub News

Media Partner

  • Practical Diabetes

Media Partner

  • Prescriber